Vestal Point Capital LP

-

Assets, Funds, Holdings

Home | Sign Up | Log In
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Vestal Point Capital LP
CRD #325894
SEC #801-127682
CIK #0001974915
AUM $2.8 B (2025-03-21)
Employees 10 (70% Investors, 0% Brokers)
Phone646-989-4000
Address632 Broadway
New York, NY 10012
Source [IAPD] [EDGAR] [Website]
Total AUM ($B)
3.02.41.81.20.60.02011201620212026
Type Form D Funds Date Sold ($M) AUM ($M)
HF Vestal Point Master Fund LP 2023-03-17 1,309.0
AUM Breakdown Accounts AUM ($B)
By Client Type
(a) Individuals (other than high net worth individuals) 0 0.0
(b) Individuals (high net worth individuals) 0 0.0
(c) Banking or thrift institutions 0 0.0
(d) Investment companies 0 0.0
(e) Business development companies 0 0.0
(f) Pooled investment vehicles 3 1.3
(g) Pension and profit sharing plans 0 0.0
(h) Charitable organizations 0 0.0
(i) State or municipal government entities 0 0.0
(j) Other investment advisers 0 0.0
(k) Insurance companies 0 0.0
(l) Sovereign wealth funds and foreign official institutions 0 0.0
(m) Corporations or other businesses not listed above 0 0.0
(n) Other 0 1.5
Total 4 2.8
By Discretionary
Discretionary 4 2.8
Non-Discretionary 0 0.0
Total 4 2.8
By Non-United States Persons
Non-United States Persons 2.2
United States Persons 0.6
Total 4 2.8
EDGAR Form CIK 2011 - 2025
13F-HR [0001974915]
SC 13G [0001974915]
Form 13D/13G Filer Form 13D/13G Subject Filed
Vestal Point Capital LP Bright Minds Biosciences Inc [2026-05-15]
Vestal Point Capital LP Aprea Therapeutics Inc [2026-05-15]
Vestal Point Capital LP Immunocore Holdings PLC [2026-05-15]
Vestal Point Capital LP Nurix Therapeutics Inc [2026-05-15]
Vestal Point Capital LP Crescent Biopharma Inc [2026-02-17]
Vestal Point Capital LP Alto Neuroscience Inc [2026-02-17]
Vestal Point Capital LP Arcellx Inc [2026-02-17]
Vestal Point Capital LP Enliven Therapeutics Inc [2026-02-17]
Vestal Point Capital LP Taysha Gene Therapies Inc [2026-02-17]
Vestal Point Capital LP Solid Biosciences Inc [2026-02-17]
Vestal Point Capital LP Day One Biopharmaceuticals Inc [2026-02-17]
Vestal Point Capital LP IBIO Inc [2025-11-14]
Vestal Point Capital LP Tenax Therapeutics Inc [2025-11-14]
Vestal Point Capital LP Lexeo Therapeutics Inc [2025-08-14]
Vestal Point Capital LP Bicara Therapeutics Inc [2025-05-15]
Vestal Point Capital LP TYRA Biosciences Inc [2025-05-15]
Vestal Point Capital LP Dianthus Therapeutics Inc /DE/ [2025-05-15]
Vestal Point Capital LP Immatics NV [2025-02-14]
Vestal Point Capital LP Nyxoah Sa [2025-02-14]
Vestal Point Capital LP Savara Inc [2025-02-14]
Vestal Point Capital LP Applied Therapeutics Inc [2025-02-14]
Vestal Point Capital LP Astria Therapeutics Inc [2024-11-14]
Vestal Point Capital LP Passage Bio Inc [2024-11-14]
Vestal Point Capital LP Black Diamond Therapeutics Inc [2024-11-14]
Vestal Point Capital LP KalVista Pharmaceuticals Inc [2024-11-14]
Vestal Point Capital LP Solid Biosciences Inc [2024-11-14]
Vestal Point Capital LP LYRA Therapeutics Inc [2024-02-13]
Vestal Point Capital LP Uniqure NV [2024-02-13]
Vestal Point Capital LP Applied Therapeutics Inc [2024-02-13]
Comparable Firms State AUM ($B)
Anson Funds Management LP
TX 2.9
Impactive Capital LP
NY 2.8
Dwight Securities Management LLC
FL 2.8
Aventail Capital Group LP
NY 2.8
140 Summer Partners LP
NY 2.8
Phase 3 Capital Management LLC
FL 2.8
Fiera Capital UK Limited
2.8
Serone Capital Management LLP
2.8
EPFC Capital Partners LLC
NY 2.8
Strategic Income Management LLC
WA 2.7
Terms | Privacy | Guide
tony@aum13f.com